Prediction of the effect of neoadjuvant chemotherapy in patients with non-small cell lung cancer of stage III at phases of combined treatment. (2016). Voprosy Onkologii, 62(4), 499-503. https://doi.org/10.37469/0507-3758-2016-62-4-499-503